3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Mesothelioma, Malignant
2
Drug-Related Side Effects and Adverse Reactions
2
Central Nervous System Neoplasms
2
Thrombocytopenia
1
Stomach Neoplasms
1
Sarcoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Pelvic Neoplasms
1
Ovarian Neoplasms
1
Optic Nerve Glioma
1
Oligodendroglioma
1
Neoplasms
1
Medulloblastoma
1
Lymphoma
1
Liposarcoma
1
Intraocular Lymphoma
1
Familial ependymoma
1
Fallopian Tube Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Colonic Neoplasms
1
Astrocytoma
1
Interventions
Paclitaxel
20
Carboplatin
16
liposomal doxorubicin
10
Bevacizumab
10
Gemcitabine
8
Topotecan
7
Taxes
7
Cisplatin
7
pembrolizumab
6
Doxorubicin
5
Cyclophosphamide
5
Nivolumab
4
fludarabine
3
Oxaliplatin
3
Immunoglobulin G
3
Hyperthermic Intraperitoneal Chemotherapy
3
Disulfides
3
Cytoreduction Surgical Procedures
3
trebananib
2
talazoparib
2
rucaparib
2
peginterferon alfa-2b
2
olaparib
2
fludarabine phosphate
2
aldesleukin
2
Surgical Procedures, Operative
2
STA 9090
2
Platinum
2
Lenalidomide
2
Irinotecan
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Fallopian Tube Neoplasms
×
sodium thiosulfate
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled